Back to calendar
Damora Therapeutics, Inc. (DMRA) Earnings
DMRA reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.48
Actual EPS: $-0.39
EPS surprise: 17.10%
Company overview
Market Cap$1.4B
PriceUSD 22.94
EPS (TTM)-124.78
52-week high38.33
52-week low4.95
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees7